Institutional Ownership
Fate Therapeutics Inc
CUSIP 31189P102COMFATEQ1 2026
Institutional Holders
151
13F filers
Shares Held
65.07M
Aggregate institutional
Institutional Value
$72.38M
Q1 2026
Net New Holders
+4
19 new · 15 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions19
Increased56
Decreased32
Sold out15
Institutional Holders
151 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Redmile Group, LLC | 12.87M | $15.45M | 0 | Held |
| 2 | Blackrock, Inc. | 10.07M | $12.08M | −107.9K | Reduced |
| 3 | Two Sigma Investments, LP | 3.47M | $4.16M | +1.73M | Added |
| 4 | Johnson & Johnson | 3.38M | $4.05M | 0 | Held |
| 5 | Aqr Capital Management LLC | 3.00M | $3.60M | +1.84M | Added |
| 6 | Renaissance Technologies LLC | 2.97M | $3.57M | +613.8K | Added |
| 7 | Geode Capital Management, LLC | 2.59M | $3.11M | +122.1K | Added |
| 8 | State Street Corp | 2.26M | $2.72M | −2.0K | Reduced |
| 9 | Ubs Group AG | 1.82M | $2.19M | +1.42M | Added |
| 10 | Goldman Sachs Group Inc | 1.33M | $1.59M | −107.3K | Reduced |
141 more institutional holders on Premium
See every fund holding Fate Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders